MEIP - MEI Pharma Inc
IEX Last Trade
3.1
-0.160 -5.161%
Share volume: 27,061
Last Updated: Fri 30 Aug 2024 09:59:45 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$3.26
-0.16
-4.91%
Summary score
34%
Profitability
43%
Dept financing
12%
Liquidity
75%
Performance
20%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Sep-2020 - 30-Sep-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-18.11%
Return on assets
-4.03%
Return on sales
-233.99%
Return on invested capital
99.52%
Total debt ratio
61.98%
Debt ratio change over timeo
0.11%
Current Ratio
6.58%
Quick Ratio
6.58%
Cash Position Ratio
6.03%
Short-term ratios 30-Sep-2023 - 30-Sep-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-1.98%
Return on assets
4.11%
Return on sales
-337.9%
Return on invested capital
201.9%
Total debt ratio
37.98%
Debt ratio change over timeo
-0.9%
Current Ratio
7.5%
Quick Ratio
7.5%
Cash Position Ratio
6.96%
Last quarter ratios 30-Sep-2024
The data are presented for the financials results of the last quarter.
Return on equity
-17.89%
Return on assets
-13.79%
Return on sales
0%
Return on invested capital
-400.66%
Total debt ratio
28.39%
Debt ratio change over time
-1.11%
Current Ratio
6.17%
Quick Ratio
6.17%
Cash Position Ratio
5.88%
Performance ratios (change over 4 years) 30-Sep-2020 - 30-Sep-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-131.08%
Return on assets
-102.94%
Return on sales
-327.48%
Return on invested capital
12.96%
Total debt ratio
11.21%
Debt ratio change over time
0.11%
Current Ratio
10.77%
Quick Ratio
10.77%
Cash Position Ratio
9.52%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | MEIP | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -18.11% | 15.05% | 36.87% | 7.05% |
| Return on assets | -4.03% | 2.92% | 3.08% | 5.46% |
| Return on sales | -233.99% | 29.91% | 31.85% | 40.26% |
| Return on invested capital | 99.52% | 2.59% | 5.31% | 18.5% |
| Profitability | 25% | 43% | 60% | 59% |
| Total debt ratio | 61.98% | 90.53% | 91.57% | 25.03% |
| Debt ratio change over time | 0.11% | 99.64% | -8.44% | 1.23% |
| Dept financing | 17% | 50% | 25% | 7% |
| Current Ratio | 7.5% | 0.9% | 1.54% | 5.47% |
| Quick Ratio | 7.5% | 0.8% | 1.06% | 4.69% |
| Cash Position Ratio | 6.96% | 0.39% | 0.54% | 2.97% |
| Liquididy | 75% | 8% | 17% | 42% |
| Short-term ratios | MEIP | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -1.98% | 12.41% | 5.03% | 4.07% |
| Return on assets | 4.11% | 2.29% | 1.19% | 2.78% |
| Return on sales | -337.9% | 24.19% | 13% | 28.34% |
| Return on invested capital | 201.9% | 1.63% | 0.67% | 9.35% |
| Profitability | 50% | 60% | 29% | 51% |
| Total debt ratio | 37.98% | 93.47% | 94.09% | 21.6% |
| Debt ratio change over time | -0.9% | 59.47% | -158.46% | 1.5% |
| Dept financing | 10% | 50% | 25% | 6% |
| Current Ratio | 7.5% | 0.9% | 1.54% | 5.47% |
| Quick Ratio | 7.5% | 0.8% | 1.06% | 4.69% |
| Cash Position Ratio | 6.96% | 0.39% | 0.54% | 2.97% |
| Liquididy | 75% | 7% | 11% | 45% |